Navigation Links
Genentech/Roche/Chugai's Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
Date:10/21/2008

Significant Unmet Need Remains for Agents that are Effective in Treating Triple-Negative Beast Cancer, According to a New Report from Decision Resources

WALTHAM, Mass., Oct. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that significant market penetration will drive Genentech/Roche/Chugai's Avastin to garner just over 20 percent of total sales in the breast cancer drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan in 2017.

The new Pharmacor report entitled Breast Cancer finds that, through 2017, the breast cancer drug market will be driven by sales of Avastin in the U.S. and Europe, its approval and launch in Japan, and its label extension to the adjuvant setting in 2013. Additionally, although Genentech/Roche/Chugai's Herceptin continues to dominate the human epidermal growth factor receptor-2 (HER2) positive breast cancer market segment, the drug is receiving strong competition from GlaxoSmithKline's Tykerb, which has received favorable physician opinion. However, Tykerb's premium price continues to limit its potential uptake, according to the report.

Market growth will also be driven by the entry of Pfizer's Sutent, currently in clinical trials, which is expected to be approved for the treatment of advanced breast cancer in 2010. Sutent's subsequent approval in the adjuvant setting between 2012 and 2017 will further drive its robust growth. Interviewed experts said they are strongly encouraged by Sutent's clinical trial data to date and express confidence in the drug's potential in breast cancer and are particularly hopeful of its potential in the treatment of triple-negative breast cancer. Triple-negative breast tumors--which account for approximately one-fifth of all breast cancers--are defined by their lack of expression of estrogen, progesterone and HER2 receptors.

"Lack of receptor expre
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Avastin Added to Chemo Helps Women With Advanced Breast Cancer
2. Avastin Added to Chemo Helps Women With Advanced Cancer
3. Off-Label Avastin Use for Wet Macular Degeneration
4. FDA OKs Avastin for Advanced Breast Cancer
5. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
6. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
7. Many More Patients Can Now Benefit from Avastins Proven Survival Benefits
8. Taxol with avastin produces noteworthy results
9. FDA Panel Says No to Avastin for Advanced Breast Cancer
10. Rising Garners Top Honors on the Private Company Indexs Top Five Growth Companies List for Q1 2008
11. Study garners unique mating photos of wild gorillas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 03, 2015 AliCare Medical Management ... management programs and a member of the Amalgamated ... Julie O’Brien as President. O’Brien formerly served as ... In her new role, she will continue with ... of AMM’s call center operations, including clinical services, ...
(Date:3/3/2015)... 2015 Aureus Medical Group (web: aureuslocumtenens.com), ... has announced that it will participate as an exhibitor ... March 17, 2015 in St. Louis, MO. , CareerMD ... job-seeking residents and fellows in a comfortable, relaxed setting. ... will be available to speak with attendees about its ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Calvary ... at their Brooklyn Satellite in Lutheran Medical Center, ... quarterly award must demonstrate excellence through clinical expertise ... also expected to go above and beyond to ... presence with patients and their families. Award recipients ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative ... tips to bring about self-renewal. A 30 day detox ... first cleaning house. According to Dr. Cutler, expert ... Between environmental toxins like heavy metals, people’s food now ... stress levels, we all have a level of toxic ...
(Date:3/2/2015)... A cocaine snorting Oscar statue ... typical nip slip or scathing scuffle. A new take ... the streets of Hollywood as Paper Jesus’ rendition of ... and substance abuse in Hollywood. The Oscar statue is ... political stance on the travails of drug addiction in ...
Breaking Medicine News(10 mins):Health News:Julie O'Brien Named President of AliCare Medical Management 2Health News:Julie O'Brien Named President of AliCare Medical Management 3Health News:Calvary Hospital Honors Peter Acerios, RN, with Daisy Award 2Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3
... a radical prostatectomy can be a viable option for ... conventional practice of generally avoiding surgeries for individuals over ... today in Urology. ,“Increased life expectancy and ... forms of anesthesia and less-invasive surgical techniques, have made ...
... and pain killers specified in the First Schedule of ... the// formulations based thereon are under price control and ... Authority (NPPA) in accordance with the provisions of the ... approved/notified price of a Schedule formulation, action is taken ...
... (USDA) today gave the ‘go-ahead’ to market a genetically-engineered ... was in a// mess just 3 months ago regarding ... The approval to market this crop came as a ... shelved any plans of commercialization of the crop. ...
... arrive at a resolution, the emergency planning cell is gearing ... a strike by medical// lab workers. The strike by ... jeopardy, including emergency surgeries. ,Dr Davies said,” Services ... testing of samples such as blood, tissues and swabs for ...
... hormone-free contraceptive pill for men they say would make them ... at King's College London, can be taken hours before sex ... a woman. However, his fertility would return to normal within ... ,Contraceptive pills available in the market now are ...
... Neurofeedback training, developed by NASA aims to help people control ... a new way of ameliorating a wide range of// ailments. ... seizures suffered by astronauts; later this technique was introduced in ... including Kyung Hee University Medical Center adopted this technique, but ...
Cached Medicine News:Health News:Octogenarians Are Not Too Old for Cancer Surgery 2Health News:Tune Your Brain To Fight Disorders 2
(Date:3/2/2015)... 2015  Akron Children,s Hospital has been designated a ... College of Radiology (ACR), making it the first hospital ... children,s hospital in the United States ... recognition from the ACR as a DICOE provides validation ... compared with national benchmarks," says Dr. Michael Rubin ...
(Date:3/2/2015)... MENLO PARK, Calif. , March ... (OTCQX: DMPI) (DelMar and the Company), a ... therapies in new orphan drug indications, today announced ... the U.S. Patent and Trademark Office (USPTO) for ... methods to improve the therapeutic benefit of suboptimally ...
(Date:3/2/2015)... , March 2, 2015 /PRNewswire/ - ESSA Pharma ... financial results for the first quarter and three months ... expressed in Canadian dollars and in accordance with International ... ESSA recorded a net loss of ... months ended December 31, 2014 (Q1-2015), compared to a ...
Breaking Medicine Technology:Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4
... testing simplified In-office. Information. In real time. The ... indications of elevated vaginal fluid pH (pH >= ... innovative format is easy to use and delivers ... Simply rub a swab containing unprocessed vaginal fluid ...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva....
... the increase in Endoscopic cases, it is extremely ... with the Surgical Light. This combination affords ... having to adopt an uncomfortable pose. The ... the NUVO Monitoring System. As such the ...
... of your procedural specialty, whether it ... NUVO Monitoring System will complement the ... ergonomics and advanced high-resolution display technology. ... mobile carts, the NUVO Monitor provides ...
Medicine Products: